Unknown

Dataset Information

0

Targeting the TREM1-positive myeloid microenvironment in glioblastoma.


ABSTRACT:

Background

Tumor cellular and molecular heterogeneity is a hallmark of glioblastoma and underlies treatment resistance and recurrence. This manuscript investigated the myeloid-derived microenvironment as a driver of glioblastoma heterogeneity and provided a pharmacological pathway for its suppression.

Methods

Transcriptomic signatures of glioblastoma infiltrated myeloid-derived cells were assessed using R2: genomic platform, Ivy Glioblastoma Spatial Atlas, and single-cell RNA-seq data of primary and recurrent glioblastomas. Myeloid-derived cell prints were evaluated in five PDX cell lines using RNA-seq data. Two immunocompetent mouse glioblastoma models were utilized to isolate and characterize tumor-infiltrated myeloid-derived cells and glioblastoma/host cell hybrids. The ability of an inhibitor of HuR dimerization SRI42127 to suppress TREM1+-microenvironment and glioblastoma/myeloid-derived cell interaction was assessed in vivo and in vitro.

Results

TREM1+-microenvironment is enriched in glioblastoma peri-necrotic zones. TREM1 appearance is enhanced with tumor grade and associated with poor patient outcomes. We confirmed an expression of a variety of myeloid-derived cell markers, including TREM1, in PDX cell lines. In mouse glioblastoma models, we demonstrated a reduction in the TREM1+-microenvironment and glioblastoma/host cell fusion after treatment with SRI42127. In vitro assays confirmed inhibition of cell fusion events and reduction of myeloid-derived cell migration towards glioblastoma cells by SRI42127 and TREM1 decoy peptide (LP17) versus control treatments.

Conclusions

TREM1+-myeloid-derived microenvironment promulgates glioblastoma heterogeneity and is a therapeutic target. Pharmacological inhibition of HuR dimerization leads to suppression of the TREM1+-myeloid-derived microenvironment and the neoplastic/non-neoplastic fusogenic cell network.

SUBMITTER: Filippova N 

PROVIDER: S-EPMC9555298 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the TREM1-positive myeloid microenvironment in glioblastoma.

Filippova Natalia N   Grimes Jeffrey M JM   Leavenworth Jianmei W JW   Namkoong David D   Yang Xiuhua X   King Peter H PH   Crowley Michael M   Crossman David K DK   Nabors L Burt LB  

Neuro-oncology advances 20220101 1


<h4>Background</h4>Tumor cellular and molecular heterogeneity is a hallmark of glioblastoma and underlies treatment resistance and recurrence. This manuscript investigated the myeloid-derived microenvironment as a driver of glioblastoma heterogeneity and provided a pharmacological pathway for its suppression.<h4>Methods</h4>Transcriptomic signatures of glioblastoma infiltrated myeloid-derived cells were assessed using R2: genomic platform, Ivy Glioblastoma Spatial Atlas, and single-cell RNA-seq  ...[more]

Similar Datasets

| S-EPMC10716967 | biostudies-literature
| S-EPMC8741448 | biostudies-literature
| S-EPMC4447552 | biostudies-literature
| S-EPMC10617775 | biostudies-literature
| S-EPMC6627125 | biostudies-literature
| S-EPMC10695587 | biostudies-literature
| S-EPMC5314811 | biostudies-other
| S-EPMC11310905 | biostudies-literature
| S-EPMC6935353 | biostudies-literature
| S-EPMC9884419 | biostudies-literature